• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • UK / Ireland

BioFilm Ltd (United Kingdom) - Dec 2007

  • unquote
  • 01 December 2007
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Tate & Lyle Ventures, an independent venture capital fund backed by Tate & Lyle Plc, and the Scottish Enterprise-managed Scottish Venture Fund have completed the acquisition of BioFilm Ltd, a manufacturer of edible films, from Devro Plc for an undisclosed sum. The deal will see the two firms take identical stakes in the business representing a combined majority interest, with the balance of the equity being provided by management. The investors were able to secure a period of exclusivity to complete the transaction due to an existing relationship between Tate & Lyle managing partner David Atkinson and BioFilm CEO Trevor Morgan. They were attracted to the business primarily due to the fact that it is the only fully-integrated manufacturer in Western Europe of edible films that carry active ingredients, the market for which is long established in North America and is beginning to emerge in Europe. The new owners are planning to invest £3m to grow the business, concentrating on re-focusing on new sectors such as medical devices and personal care. The deal was finalised on 28 December 2007 and took just six weeks to complete.

Company

Hamilton-based BioFilm develops and manufactures fast dissolving films used for food supplements and medical applications. The benefits of these products, which include their ease of use, cost effectiveness and, in some cases, increased absorption through the buccal membrane (inside cheek), has recently led to their increasing use as medical devices, such as anti-snoring strips, and as a delivery system for a range of active ingredients, including breath fresheners, nutraceuticals, cosmeceuticals and drugs. The company was founded in 2003 and employs 28 staff.

People

David Atkinson and Simon Barnes worked on the transaction for Tate & Lyle Ventures, with Atkinson joining the BioFilm board, while Jonathan Lloyd-Hirst led the investment for Scottish Enterprise. Trevor Morgan represented the company.

Advisers

Equity - Bird & Bird, Angus Miln (Legal)Equity - Burness Solicitors , (Legal)Management - John Jackson & Dick, Euan Stirrat (Legal)Vendor - MacRoberts, Ian Dickson (Legal)

Sourced from: UK & Ireland unquote" 361 (Jan 2008)

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • UK / Ireland
  • Buyouts
  • Industrials
  • United Kingdom

More on UK / Ireland

Inflexion to exit Xtrac in SBO to MiddleGround Capital
Inflexion to exit Xtrac in SBO to MiddleGround Capital

Sale of UK-based transmission-systems manufacturer marks Buyout Fund IVт€™s seventh exit

  • UK / Ireland
  • 31 July 2023
Federated Hermes raises USD 486m for fifth co-investment fund
Federated Hermes raises USD 486m for fifth co-investment fund

Fund surpassed its USD 400m target; its 2018-vintage predecessor raised USD 600m against a USD 350m target

  • UK / Ireland
  • 12 July 2023
FPE Capital acquires, merges NoBlue and Elevate2
FPE Capital acquires, merges NoBlue and Elevate2

GPт€™s investment in NetSuite partners marks fifth investment out of third fund

  • UK / Ireland
  • 11 July 2023
Palatine reaps 6x money on SBO of Anthesis to Carlyle
Palatine reaps 6x money on SBO of Anthesis to Carlyle

GP will be reinvesting in UK-headquartered sustainability firm, acquiring a minority stake

  • UK / Ireland
  • 03 July 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013